Disclosures for "CAR-T Cell Therapy for Multiple Sclerosis: A Systematic Review of Emerging Clinical, Safety, and Biomarker Evidence"
-
Dr. De Siqueira Lima has nothing to disclose.
-
José Felipe Lacerda Fernandes has nothing to disclose.
-
Author has nothing to disclose
-
Mr. Vasconcelos has nothing to disclose.
-
Dr. OLIVEIRA has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MERCK. Dr. OLIVEIRA has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NOVARTIS. Dr. OLIVEIRA has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AMGEN. Dr. OLIVEIRA has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NOVARTIS. Dr. OLIVEIRA has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MERCK.